History | Obinutuzumab with bendamustine for treating follicular lymphoma after rituximab | Guidance | NICE

History

Expected publication

Equality Impact Assessment (Guidance development) (PDF 124 KB)

Published:

13 May 2020

Declaration of interests

Register of interests (PDF 160 KB)

Published:

13 May 2020

Final draft guidance

Final draft guidance
Final appraisal document (PDF 242 KB)

Published:

03 April 2020
Committee papers (PDF 4.55 MB)

Published:

03 April 2020
Public committee slides (PDF 904 KB)

Published:

03 April 2020

Invitation to participate

Final scope (PDF 103 KB)

Published:

18 October 2019
Final stakeholder list (PDF 218 KB)

Published:

18 October 2019